Integrated Bio-behavioral Survey (IBBS) among Male Injecting Drug Users (IDUs) in the Western and the Far-Western Terai - 2007. New ERA, STD/AIDS Counseling and Training Services, FHI, et al (2008)

Integrated Bio-behavioral Survey (IBBS) among Male Injecting Drug Users (IDUs) in the Western and the Far-Western Terai - 2007. USAID and Advancing Surveillance Policies Prevention Care and Support to Fight HIV/AIDS (2008) The National Center for AIDS and STD Control (NCASC), Nepal, has developed a comprehensive National Surveillance Plan for HIV and AIDS that includes a regular schedule for conducting an Integrated Biological and Behavioral Survey (IBBS) among most at risk populations (MARPs). These surveillance studies, conducted at regular intervals, help to assess health risk behaviors, to measure the prevalence of HIV and Sexually Transmitted Infections (STIs) among MARPs and to monitor trends in the epidemic to inform the HIV response in Nepal.

Download this publication

National Behavioural Surveillance Survey (BSS) 2006: Men who have Sex with Men (MSM) and Injecting Drug Users (IDUs). National AIDS Control Organisation (2008)

National Behavioural Surveillance Survey (BSS) 2006: Men who have Sex with Men (MSM) and Injecting Drug Users (IDUs). National AIDS Control Organisation (2008) The aim of carrying out the National BSS 2006 was to assess current risk behaviour in specific population groups in India and to develop a database so as to measure behavioural changes from National BSS 2001 to National BSS 2006. The present report would provide the detailed findings of BSS 2006 conducted among two high-risk population groups of IDUs and MSM, about their awareness, knowledge, attitude and behaviour with regards to STD/HIV/AIDS.

Download this publication

National Harm Reduction Strategy for Drug Use and HIV 2004-2010. National AIDS/STD Programme (2008)

A Review of Strategies and Policies of the National Anti-Drugs Agency. Kaur S (2009)

In Bangladesh it is widely acknowledged that drug use is increasing and accompanied with this are various risk behaviors. Particular concerns are injecting drug use and adverse health consequences such as blood borne viruses specifically HIV/AIDS and Hepatitis C.


Download this publication

Offering Afghan Drug Addicts a Clean Break. ADB (2008)

Offering Afghan Drug Addicts a Clean Break. ADB (2008)

A nongovernment organization working in Afghanistan's capital, Kabul, is trying to clean up addicts in the fight against HIV/AIDS.

In addition to the usual needle and syringe exchange schemes, NGO NEJAT Center is providing simple amenities – soap and shampoo, a bath, a scrub, clean clothes and a haircut – to drug users as a step toward rehabilitation.



Download this publication

Predictors of HIV Infection and Prevalence for Syphilis Infection among Injection Drug Users in China. Jia Y, Lu F, Zeng G, et al (2008)

Predictors of HIV Infection and Prevalence for Syphilis Infection among Injection Drug Users in China. Jia Y, Lu F, Zeng G, et al (2008) Prevalence rates of HIV among IDUs in China are more than two out of three in some venues. Risk factors include longer duration of IDU and needle sharing. Also associated with HIV were factors that may indicate some success in education in higher risk persons, such as higher knowledge. A systemic community-level intervention with respect to evidenced-based, population-level interventions to stem the spread of HIV from IDU in China should include needle exchange, opiate agonist-based drug treatment, condom distribution along with promotion, and advocacy for community-based VCT with bridges to HIV preventive services and care.

Download this publication

Preventing and Treating Opiates Addiction and HIV/AIDS Epidemics in Afghanistan and Neighbouring Countries. UNODC (2008)

cover-coming-soon The South West and Central Asian region comprising Afghanistan, the Islamic Republic of Iran and Pakistan in the South West and Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan in Central Asia, have one of the highest prevalence of opioid use – heroin, opium and other opiates, in the world. While most countries in this region have had a long history of traditional opium use among certain sections in the society, the emergence of heroin in the local markets in the past decades has resulted in a surge of heroin and other opiates use with social and health consequences for the drug users as well as the society at large.

Download this publication

Public Health Fact Sheet: Police, Harm Reduction, and HIV. Open Society Institute Public Health Program and International Harm Reduction Development Program (2008)

Public Health Fact Sheet: Police, Harm Reduction, and HIV. Open Society Institute Public Health Program and International Harm Reduction Development Program (2008) Injecting drug users (IDUs) account for the largest share of HIV infections in China, Russia, Ukraine, Central Asia, and much of Southeast Asia. Harm reduction measures such as access to clean needles and drug treatment with methadone or buprenorphine have been proven to reduce HIV risk behaviors. Yet law enforcement officials in many countries harass drug users at drug treatment clinics and needle exchange points, confiscate their medications, or arrest them for possession of clean syringes. These police practices help fuel the HIV epidemic by driving drug users away from lifesaving care while doing little to stem drug use. Emerging partnerships between police and health providers prove that law enforcement and HIV prevention programs can work together to save lives while reducing crime.

Download this publication

Rapid Situation and Response Assessment of Drugs and HIV in Bangladesh, Bhutan, India, Nepal and Sri Lanka. UNODC, DFID and AusAID (2008)

Rapid Situation and Response Assessment of Drugs and HIV in Bangladesh, Bhutan, India, Nepal and Sri Lanka. UNODC, DFID and AusAID (2008) Injecting drug use (opioids and pharmaceuticals) and HIV associated with injecting drug users (IDUs), has diffused rapidly in the South Asian region. Further, the sexual transmission of HIV from the IDUs to their non-injecting sexual partners has been established. Developing appropriate responses to this emerging problem requires a rapid situation and response assessment (RSRA) of drug users and their regular sexual partners.

Download this publication

The Global State of Harm Reduction 2008 Mapping the Response to Drug-related HIV and Hepatitis C Epidemics. Cook C and Kanaef N (2008)

A Review of Strategies and Policies of the National Anti-Drugs Agency. Kaur S (2009)

The term ‘harm reduction’ refers to policies and programmes aimed at reducing the health, social and economic harms associated with the use of illicit and licit psychoactive substances. Harm reduction is entrenched in both public health and human rights rationales, and takes a pragmatic and non-judgemental approach to addressing the problems associated with drug use.


Download this publication

The Hidden Truth: A Study of HIV Vulnerability, Risk Factors and Prevalence among Men Injecting Drugs and their Wives. Punjab AIDS Control Program and UNAIDS (2008)

The Hidden Truth: A Study of HIV Vulnerability, Risk Factors and Prevalence among Men Injecting Drugs and their Wives. Punjab AIDS Control Program and UNAIDS (2008) In Pakistan injecting drug use is recognized as the main driver of the HIV epidemic due to high levels of needle/syringe sharing and insufficient HIV prevention services. Previous studies have assessed IDUs as a “most at risk population”, and have missed the opportunity to understand the related risks and vulnerability of their families and communities.The “Hidden Truth” has revealed previously unrecognized risks and vulnerability of wives of injecting drug users (IDUs) in Pakistan.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Jul
28
(28 Jul - 28 Jul)
Aug
12
(12 Aug - 12 Aug)